The Food and Drug Administration late last night amended Pfizer’s emergency use authorization for its COVID-19 vaccine to allow for an additional, booster dose for certain individuals. FDA will authorize a booster shot to be administered six months following a completed two-dose regiment for the following:

  • individuals 65 years of age and older; 
  • individuals in the 18-64 age range who are at high risk of severe COVID-19; and
  • individuals in the 18-64 age range whose frequent institutional or occupational exposure to SARS-CoV-2 puts them at high risk of serious complications of COVID-19, including severe disease.

The Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices today advanced the possibility of booster shots, voting unanimously to recommend boosters for the 65-and-older age group and people in long-term care facilities. ACIP also fully recommended giving a single booster dose to people between the ages of 50 and 64 with certain high risk conditions.

The ACIP meeting was continuing at the time of AHA Today’s publication, with the committee discussing occupational exposure issues that may warrant a booster. AHA tomorrow will update members on this issue.

Related News Articles

Headline
The Centers for Disease Control and Prevention Friday updated its COVID-19 infection control guidance for U.S. health care settings based on current…
Headline
The Food and Drug Administration yesterday advised people who get a negative result from an at-home COVID-19 antigen test to test themselves again after…
Headline
The Centers for Disease Control and Prevention today released updated guidance to help people protect themselves and others if they are exposed to, sick or…
Headline
The Food and Drug Administration today granted full approval of Pfizer’s COVID-19 vaccine for young teens, covering the age group spanning 12 to 15 years old.…
Headline
The Food and Drug Administration today authorized state-licensed pharmacists to prescribe Paxlovid (nirmatrelvir and ritonavir) to patients as a treatment…
Blog
Understanding potential costs is an important part of the patient experience when planning for care, and hospitals and health systems are committed to helping…